Navigation Links
Namocell, Takara Bio USA and HepaTx collaborate on single cell genomics analysis for cell therapy to treat late-stage liver diseases
Date:2/21/2020

Namocell Inc., a leading provider of single cell sorting and dispensing platforms, announced today that it has entered into a collaboration with Takara Bio and HepaTx to use Namocell’s Single Cell Dispensers to perform single cell isolation on HepaTx’s unique hepatocyte-like cells (iHeps) developed from adipose tissue-derived stromal cells (ASCs), and characterize them by single cell RNA-seq (scRNA-seq) using Takara Bio’s SMART-seq® technology.

“We are excited to collaborate with Takara and HepaTx to leverage our unique single cell sorting and dispensing platform to support HepaTx’s innovative stem cell- based cell therapy that could revolutionize the treatment of late-stage liver diseases by replacing liver transplants. Namocell’s fast and gentle sorting and dispensing technology is enabling superior cell isolation for single cell analysis,” said Dr. Junyu Lin, CEO of Namocell.

“We are excited to be working with Namocell and HepaTx and contribute to the development of an innovative clinical solution. Leveraging our SMART-seq technology with Namocell’s single cell dispenser is an ideal match for performing plate based single cell RNA-seq enabling researchers to perform full length sequence analysis on single cells providing a deeper view into gene expression and cellular differentiation,” said Dr. Suvarna Gandlur, Associate Director of Next Generation Sequencing at Takara Bio USA.

“Namocell’s and Takara’s single cell technologies will help us advance our cell therapy platform to the clinic more quickly by enabling a deep molecular view of our development product. This will help us reach our goal of providing a scalable solution that can address clear clinical needs and provide better alternatives to liver transplants for patients,” said Dr. Eric Schuur, CEO of HepaTx.

About Namocell

Namocell provides innovative single cell sorting and dispensing platforms to empower single cell research and therapeutics development. Namocell’s single cell dispensers are the fastest and easiest way to identify and isolate single cells, and enable users to accomplish single cell sorting and dispensing in one step in a way that is gentle to live cells. We serve researchers and scientists in a wide range of applications, including single cell genomics, cell line development, CRISPR, cell therapy, stem cell, monoclonal antibody development, rare cell isolation, and synthetic biology. Learn more at http://www.namocell.com.

About HepaTx

HepaTx is a regenerative medicine company developing new types of stem cell-based treatments for patients with late stage liver disease, a highly underserved and cost intensive market. HepaTx’s proprietary process, licensed from Stanford and well protected by licensed IP, differentiates adipose stromal cells obtained from discarded lipoaspirate into functional hepatocytes. These hepatocytes are directly infused into the liver where they regenerate liver function. To learn more, visit our website, Hepatx.com and follow us on Twitter, @hepatx.

About Takara Bio USA

Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for life science applications, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sample preparation.

Read the full story at https://www.prweb.com/releases/namocell_takara_bio_usa_and_hepatx_collaborate_on_single_cell_genomics_analysis_for_cell_therapy_to_treat_late_stage_liver_diseases/prweb16923622.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. EconoFact Collaborates with Macmillan Learning to Enhance Digital Learning Materials for Economics Courses
2. Abveris and Geneious Biologics Collaborate to Advance Antibody NGS Data Analysis
3. Abcam Collaborates with Visikol to Develop New Tools for Improved Tissue Clearing and 3D Imaging
4. Omixon & PIRCHE® collaborate on Epitope Determination with NGS
5. Syngrafii & San Antonio Credit Union (SACU) Collaborate on Remote Document Execution
6. Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices
7. NSF and NIH collaborate to accelerate advance of biomedical innovations into the marketplace
8. NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
9. EU initiative Climate-KIC and regional innovation network ERRIN to collaborate
10. UTMB collaborates on program targeting potential bioterrorist pathogens Ebola and Marburg
11. Researchers collaborate to reduce effects of the aging eye
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2020)... , ... August 05, 2020 , ... Regenative Labs has ... new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be ... a syringe. The company’s solutions are the first Wharton’s jelly allograft product to be ...
(Date:7/22/2020)... ... July 21, 2020 , ... ... and innovation in technology and compliance, announces a new solution to manage regulated ... ensure every layer of their technology stack complies with FDA and global regulations. ...
(Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient MasterClass ... is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of savory ... at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting & ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... Diversified Technologies, Inc. has introduced a full ... drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... push-pull configuration; yielding fast fall time for a capacitive load. These all solid-state ...
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory Gating ... countries, has reached its 20th anniversary of worldwide use. Introduced in the US ... universities including University of Pennsylvania, University of Michigan, University of Maryland, University of ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this ... the only technology of its kind on the market and we were pleased that ... protective capacity of traditional cultured ingredients, creating a natural way to extend the shelf ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
Breaking Biology Technology: